Scholars Central

Case reportPublished 27 May 2024

Synchronous Adenocarcinoma of the Ovary and Endometrium: A Case Report

Authors: Montacer Hafsi, Marwa Moussi, Asma Zouaghi, Sarra Rihani, Faten Dridi, Souhir Najar, Smaoui Maroua, Mechaal Mourali

Journal of Women's Health Care

Volume 13 · Issue 5 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction and importance: Synchronous occurrence of endometrial and ovarian cancers, particularly when they share the same histological type, presents diagnostic and therapeutic complexities. This case report highlights the challenges and nuances in diagnosing and managing such synchronous malignancies, emphasizing the need for meticulous evaluation and tailored therapeutic strategies. Case presentation: A 46-year-old female (G.S) presented with chronic pelvic pain and abnormal uterine bleeding. Clinical examination revealed an enlarged uterus and masses in the left iliac fossa and ovaries. Imaging studies, including ultrasound and CT scans, indicated bilateral ovarian masses and peritoneal carcinosis. Histopathological examination following surgical intervention confirmed bilateral infiltrating grade II endometrioid adenocarcinoma involving the endometrium and ovaries. Clinical Discussion: Synchronous endometrial and ovarian cancers, accounting for a substantial proportion of gynecological synchronous cancers, present predominantly in women around 53 years old, often affecting younger individuals with the endometrioid type. Differential diagnosis necessitates evaluating multiple clinicopathological factors to distinguish between primary tumors and metastatic disease. Recent molecular studies suggest the possibility of a continuum in these malignancies, indicating a potential origin in endometrial foci. Lynch syndrome is prevalent in a subset of cases. Treatment typically involves surgical intervention followed by neoadjuvant radiotherapy and chemotherapy. Conclusion: The coexistence of synchronous ovarian and endometrial cancers poses diagnostic complexities that demand thorough investigation, including immunohistochemical, molecular, and genomic analysis. Accurate confirmation through targeted sequencing is crucial for tailored management strategies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Women's Health Care.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Women's Health Care
  • SubjectNursing & Healthcare
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Montacer Hafsi”
  • BylineArticles whose byline prints “Marwa Moussi”
  • BylineArticles whose byline prints “Asma Zouaghi”
  • BylineArticles whose byline prints “Sarra Rihani”
  • BylineArticles whose byline prints “Faten Dridi”
  • BylineArticles whose byline prints “Souhir Najar”
  • BylineArticles whose byline prints “Smaoui Maroua”
  • BylineArticles whose byline prints “Mechaal Mourali”